U.S. Personal Products Stock News

In the past week, NetScout Systems reported second quarter fiscal 2026 results with both earnings per share and revenue coming in well above analyst expectations, while director Christopher Perretta sold 10,000 shares under a pre-arranged trading plan. The earnings beat highlights stronger-than-anticipated demand for NetScout’s network visibility and cybersecurity offerings, sharpening investor focus on how its AI-enabled solutions and enterprise exposure are shaping the company’s long-term...

If you have been wondering whether Intel is still a bargain after its huge rebound, you are not alone. This article is going to unpack exactly what the current price is really offering. After a rocky few years, Intel's share price has surged, up 82.1% year to date and 88.6% over the last year, even though it pulled back about 2.6% over the past week. Part of this renewed interest comes from Intel pushing aggressively into foundry services to compete with TSMC and seeking major government...

In recent days, TikTok’s parent ByteDance agreed to form a U.S.-based joint venture with Oracle, Silver Lake, and MGX, under which Oracle will oversee TikTok’s U.S. data protection, content moderation, and algorithm security while hosting the platform on its cloud infrastructure. This agreement not only expands Oracle’s cloud workload with a high-traffic consumer app, it also elevates the company’s role in U.S. digital governance and national security-sensitive data oversight. We’ll now...

Zions Bancorporation recently delivered a strong Q3, with revenue rising 9.3% year on year and both revenue and EPS exceeding analyst expectations, benefiting from higher interest rates and ongoing digital banking investments. The results highlight how Zions’ mix of technology upgrades and regional lending strength is helping it stand out among regional banks facing fintech competition and credit risks. We’ll now examine how this earnings beat, alongside improving digital capabilities, may...

Braze (BRZE) has had a busy stretch, with revenue beating expectations, guidance nudged higher, and fresh Buy coverage from BTIG all landing within days. Naturally, investors are asking what comes next. See our latest analysis for Braze. Those upbeat results and new coverage have lit a fire under sentiment, with the 30 day share price return of 30.31 percent standing out against a still negative year to date share price performance. This suggests momentum is rebuilding after a choppy stretch...

Kymera Therapeutics (KYMR) just gave investors a one two punch of good news, with upbeat Phase 1b data for its oral STAT6 degrader KT-621 in atopic dermatitis and an FDA Fast Track designation. See our latest analysis for Kymera Therapeutics. The latest Fast Track nod and strong KT-621 data help explain why Kymera’s 30 day share price return is 29.57% and year to date share price return is 105.40%. This reinforces an already powerful 3 year total shareholder return of 217.18% and suggests...

Earlier this month, Digital Realty Trust announced that Stephen R. Bolze, a veteran infrastructure and industrial executive with leadership experience at Blackstone and General Electric, was elected as an independent director effective January 1, 2026, and will join the Audit Committee. His deep background in power and large-scale infrastructure could be especially important for a data center operator increasingly focused on energy-hungry AI workloads and capacity expansion. Next, we’ll...

Earlier in 2025, American Tower Corporation reported strong Q3 results, with revenue and net income beating expectations helped by favorable foreign currency movements. The company is sharpening its focus on developed markets while rapidly expanding its CoreSite data center platform to capture rising AI-related demand. Next, we’ll examine how this renewed emphasis on CoreSite’s AI-driven data center growth could reshape American Tower’s investment narrative. Explore 28 top quantum computing...

Fresh Del Monte Produce (FDP) is back on investors radar as bullish coverage focuses on its improving balance sheet, ongoing share buyback, and the potential for stronger cash returns over the next year. See our latest analysis for Fresh Del Monte Produce. At a share price of $37.55, Fresh Del Monte’s recent 8.8 percent 1 month share price return and 16.7 percent 1 year total shareholder return suggest momentum is quietly building as buybacks, divestitures, and debt reduction reshape the risk...

Worthington Enterprises (WOR) has been quietly reshaping itself into a focused consumer and building products manufacturer, and the stock’s recent pullback has investors wondering whether this is a fresh entry point or a pause. See our latest analysis for Worthington Enterprises. After a strong run earlier in the year, Worthington’s recent 7 day share price return of negative 10.25 percent and 90 day share price return of negative 14.22 percent suggest momentum is cooling, even though the 3...

DXC Technology (DXC) just launched AdvisoryX, a global advisory group focused on helping enterprises turn AI ambition into execution, backed by a detailed study on how leaders are actually deploying AI today. See our latest analysis for DXC Technology. Those moves around AdvisoryX and DXC's new Chief Digital Information Officer seem to have caught investors' attention, with a 30 day share price return of 28.69 percent helping reverse some of the deeper multiyear total shareholder return...

Cooper Companies (COO) just drew fresh attention after White Albert G III, head of its CooperVision unit, bought another 10,000 shares, extending a year long pattern of insider purchases without any sales. See our latest analysis for Cooper Companies. That confidence has coincided with improving sentiment, with a roughly 21% 3 month share price return helping to offset weaker year to date and 1 year total shareholder returns that remain in negative territory. This suggests momentum may be...

PTC Therapeutics (PTCT) just secured Health Canada approval for Sephience, extending its phenylketonuria treatment to a wide range of Canadian patients and building on earlier US and European green lights. See our latest analysis for PTC Therapeutics. The Sephience approval lands as momentum in PTC Therapeutics' shares has been building, with a roughly 30 percent 3 month share price return and about 70 percent 1 year total shareholder return. This underscores how regulatory wins are reshaping...

Belden (BDC) has quietly delivered a mixed return profile, with the stock up about 4% year to date but down roughly 10% over the past 3 months, prompting fresh interest in its valuation. See our latest analysis for Belden. That pattern fits a stock where sentiment has cooled recently, even as the longer term story remains constructive, with solid double digit multi year total shareholder returns suggesting resilience beneath the latest share price pullback. If Belden has you thinking about...

Recently, Willdan Group reported strong earnings, raised its 2025 financial targets, and completed the acquisition of Alternative Power Generation, Inc., expanding its AI-driven energy infrastructure capabilities. This combination of upgraded guidance, growing utility-focused software and analytics contracts, and enhanced data-center solutions highlights Willdan’s emerging role in supporting the U.S. energy transition. Next, we’ll explore how Willdan’s upgraded guidance and AI-focused...

Allegro MicroSystems (ALGM) climbed about 4% after Micron Technology issued an upbeat revenue forecast, which lifted sentiment across semiconductor names and signaled healthier demand and pricing for AI exposed chipmakers. See our latest analysis for Allegro MicroSystems. Today’s move comes after a choppy stretch, with a roughly 15% 3 month share price decline followed by a near 15% 1 month share price rebound. This suggests momentum is tentatively returning despite a stronger 1 year total...

Uranium Energy Corp. reported first‑quarter 2025 results to October 31, 2025, narrowing its net loss to US$10.34 million from US$20.16 million a year earlier, with basic and diluted loss per share from continuing operations improving to US$0.02 from US$0.05. At the same time, the company’s shift from developer to producer, acquisition of the Sweetwater Complex, and launch of a refining and conversion subsidiary have begun to define Uranium Energy as a vertically integrated U.S. uranium...

On December 18, 2025, AbCellera Biologics announced it had resolved its global patent litigation with Bruker Corporation through a settlement and patent license agreement, under which Bruker will pay AbCellera US$36 million upfront plus ongoing royalties on sales of its Beacon Optofluidic platform products for the life of the licensed patents. This deal not only removes legal uncertainty but also adds a new royalty stream that could complement AbCellera’s transition toward downstream,...

Wondering if CarMax is a beaten down bargain or a value trap at current levels? This article will walk you through what the stock price is really implying. After sliding 6.2% over the last week, CarMax is still up 12.5% for the past month, yet it remains deeply underwater with a -52.6% year to date return and -54.3% over the last year. Those sharp moves have come as investors reassess used car demand, financing costs, and consumer credit conditions, while also watching how CarMax adapts to...

Wondering if QUALCOMM is still a smart buy after its big run, or if most of the upside is already priced in? This article breaks down what the current share price really implies. The stock has slipped about 1.7% over the last week but is still up 5.5% in the past month, 14.1% year to date, and 17.2% over the last year, hinting at solid momentum despite short term volatility. That move has come as investors double down on the semiconductor and wireless infrastructure story, with QUALCOMM...

QuantumScape (QS) is back in the spotlight after signing a joint development agreement with a top-10 global automaker and deepening ties with Volkswagen’s PowerCo, moves that signal real progress toward commercial solid-state batteries. See our latest analysis for QuantumScape. The flurry of new OEM deals, PowerCo support and progress on the Eagle Line has arrived after a choppy few weeks, with a 30 day share price return of negative 8.27 percent but a powerful year to date share price return...

Earlier this week, Jim Cramer highlighted Corning Incorporated’s push to replace copper with optical fiber in data centers and underscored its long-running specialty glass relationship with Apple after visiting one of its manufacturing facilities. The commentary brought fresh attention to Corning’s role in enabling AI-focused data centers, framing its fiber and glass technologies as core infrastructure rather than just components. We’ll now explore how this renewed focus on Corning’s fiber...

If you are wondering whether Palo Alto Networks is still worth buying at today's price, you are not alone. This stock sits at the crossroads of cybersecurity hype and long term fundamentals. Despite short term moves like a 2.5% dip over the last week and a 6.5% slide over the past month, longer horizons look much stronger, with the stock up 164.6% over 3 years and 205.4% over 5 years. Those swings have come as Palo Alto Networks continues to consolidate its platform and push deeper into AI...

If you are wondering whether e.l.f. Beauty is a bargain again or still priced for perfection, especially after its huge multi year run, you are not alone in trying to figure out what a fair entry point looks like now. The stock has bounced recently, rising 5.3% over the last week and 12.9% over the past month. That is still against a much tougher backdrop, with returns of -34.6% year to date and -37.5% over the last year, following a 47.7% gain over three years and a 244.6% gain over five...